Switch to:

Beam Therapeutics Research & Development

: $66.99 Mil (TTM As of Mar. 2020)
View and export this data going back to 2020. Start your Free Trial

This is the expense the company spent on research and development. Beam Therapeutics's research and development for the three months ended in Mar. 2020 was $21.55 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2020 was $66.99 Mil.


Beam Therapeutics Research & Development Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Beam Therapeutics Annual Data
Dec17 Dec18 Dec19
Research & Development 0.00 33.87 54.62

Beam Therapeutics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Research & Development Premium Member Only Premium Member Only 9.18 12.68 12.54 20.22 21.55

Beam Therapeutics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2020 was 12.68 (Jun. 2019 ) + 12.543 (Sep. 2019 ) + 20.217 (Dec. 2019 ) + 21.549 (Mar. 2020 ) = $66.99 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Beam Therapeutics  (NAS:BEAM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Beam Therapeutics Research & Development Related Terms


Beam Therapeutics Research & Development Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)